Literature DB >> 10620188

Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells.

W Eberhardt1, T Beeg, K F Beck, S Walpen, S Gauer, H Böhles, J Pfeilschifter.   

Abstract

UNLABELLED: Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells.
BACKGROUND: High-output levels of nitric oxide (NO) are produced by rat mesangial cells (MCs) in response to proinflammatory cytokines such as interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) by the inducible isoform of NO synthase (iNOS). We tested modulatory effects of NO on the expression and activities of matrix metalloproteinases-9 and -2 (MMP-9 and MMP-2), respectively. Temporal and spatial expression of these MMPs and their specific inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), seems to be critical in the extensive extracellular matrix (ECM) remodeling that accompanies sclerotic processes of the mesangium. Methods and Results. Using the NO donors S-Nitroso-N-acetyl-D,L-penicillamine (SNAP) and DETA-NONOate, we found strong inhibitory effects of NO mainly on the IL-1beta-induced MMP-9 mRNA levels. NO on its own had only weak effects on the expression of MMP-9 and MMP-2. The addition of the NOS inhibitor NG-monomethyl L-arginine (L-NMMA) dose dependently increased steady-state mRNA levels of cytokine-induced MMP-9, suggesting that endogenously produced NO exerts tonic inhibition of MMP-9 expression. MMP-9 activity in conditioned media from MCs costimulated with IL-1beta and NO donor contained less gelatinolytic activity than media of cells treated with IL-1beta alone. Exogenously added NO did not alter gelatinolytic activity of MMP-9 in cell-free zymographs. The expression levels of TIMP-1 were affected by NO similarly to the expression of MMP-9.
CONCLUSION: We conclude that NO modulates cytokine-mediated expression of MMP-9 and TIMP-1 in rat MCs in culture. Our results provide evidence that NO-mediated attenuation of MMP-9 gelatinolytic activity is primarily due to a reduced expression of MMP-9 mRNA, and not the result of direct inhibition of enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620188     DOI: 10.1046/j.1523-1755.2000.00808.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

Review 1.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

2.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

3.  Nitric oxide (NO), methylation and TIMP-1 expression in BL6 melanoma cells transfected with MHC class I genes.

Authors:  X Huang; A Orucevic; M Li; E Gorelik
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Wolfgang Eberhardt; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.

Authors:  Min-Hua Sun; Xi-Chun Han; Ming-Ku Jia; Wei-Dong Jiang; Min Wang; Hong Zhang; Gang Han; Yi Jiang
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

6.  Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.

Authors:  Nan Xie; Samira Khabbazi; Zeyad D Nassar; Kye Gregory; Tharindu Vithanage; Bela Anand-Apte; Peter J Cabot; David Sturgess; Paul N Shaw; Marie-Odile Parat
Journal:  FASEB J       Date:  2017-08-07       Impact factor: 5.191

7.  Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR.

Authors:  El-Sayed Akool; Hartmut Kleinert; Farid M A Hamada; Mohamed H Abdelwahab; Ulrich Förstermann; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.

Authors:  Cesar A Meschiari; Tatiane Izidoro-Toledo; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

9.  Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.

Authors:  Jiqian Huang; Helmy M Siragy
Journal:  Endocrinology       Date:  2009-10-27       Impact factor: 4.736

10.  Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function.

Authors:  Andrés Barrilli; Sara Molinas; Guillermo Petrini; Mauricio Menacho; María Mónica Elías
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.